
1 - 2 of 2 News Articles
Page: [1]
BPL is delighted to support the 20th International Workshop on “Surveillance and Screening of Blood Borne Pathogens”, jointly organised by the International Plasma Fractionation Association (IPFA) and the Paul-Ehrlich-Institut (PEI).The 2013 Event marks the 20th anniversary of the Workshop and will be hosted ...
Date added: Monday 22nd October 2012
Gammaplex has Marketing Authorisation extended with new clinical indications BPL is delighted to announce that the UK Marketing Authorisation for Gammaplex has been extended to include the following new indications: ITP (Immune thrombocytopenic purpura), GBS (Guillain Barré syndrome), Kawasaki disease and Hypogammaglobulinaemia in patients after allogeneic ...
Date added: Friday 27th April 2012